Clinical Trials Insight: 700033183

Trial Profile

Clinical Trials Insight: 700033183

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 05 May 2008

At a glance

  • Drugs AMG 222 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Amgen
  • Most Recent Events

    • 05 May 2008 New trial record.
    • 25 Apr 2008 Results are expected in late 2008 or early 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top